Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35474

H4C1 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

H4C1 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the H4C1 gene, which encodes the histone H4 core nucleosome component, in human Ca Ski cervical carcinoma cells. This HPV-16-positive epithelial model enables investigation of H4C1 loss-of-function effects on chromatin structure and gene regulation, involving factors such as E2F1, NPAT, and the histone chaperone CAF-1. The knockout cells are suitable for chromatin biology, oncogenic signaling, and epigenetic research, supporting assays like western blotting, RNA-seq, and cell cycle analysis. They serve as a tool to explore DNA replication stress and histone-dependent transcriptional regulation in a cancer-relevant context.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    H4C1

    Gene Identifier

    NCBI Gene ID 8359

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H4C1 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human cervical carcinoma cell line Ca Ski. This product features targeted disruption of the H4C1 gene (also known as HIST1H4C), which encodes histone H4, a core nucleosome component. The polyclonal format provides a heterogeneous pool of knockout cells, each carrying distinct CRISPR/Cas9-mediated indels in the target locus, allowing investigation of H4C1 loss-of-function effects without the need for single-cell clone isolation.

The parental Ca Ski cell line is an adherent epithelial cell line derived from a cervical carcinoma metastasis. It is widely used as a model for HPV-16-driven oncogenesis, as it harbors integrated HPV-16 genomic DNA and constitutively expresses the viral oncoproteins E6 and E7, which disrupt the p53 and retinoblastoma tumor suppressor pathways, respectively. This background makes Ca Ski cells particularly suitable for studying the interplay between host chromatin regulation and viral oncogene expression.

Histone H4, encoded by H4C1, is an essential component of the nucleosome core particle, where it interacts with histones H2A, H2B, and H3 to form the octameric histone core. H4C1 expression is tightly regulated during the cell cycle, primarily by the CDK2/cyclin E kinase complex and the transcription factors E2F1 and NPAT, which coordinate histone gene transcription with DNA replication. The histone H4 protein serves as a substrate for multiple post-translational modifications, including acetylation and methylation, which are added by histone acetyltransferases and methyltransferases and recognized by chromatin remodelers and reader proteins. Histone H4 functions downstream of replication-dependent histone chaperones such as CAF-1 and ASF1, which facilitate its deposition onto newly replicated DNA. Through its structural role, H4 contributes to chromatin compaction, nucleosome stability, and the regulation of gene expression programs. H4C1 knockout is thus expected to disrupt these fundamental processes, leading to altered nucleosome assembly and chromatin organization.

In the Ca Ski cervical carcinoma model, loss of histone H4 function is anticipated to induce profound chromatin defects that may intersect with HPV-driven oncogenic pathways. The E6 and E7 oncoproteins are known to interact with epigenetic modulators and influence host gene expression; therefore, H4C1 knockout could affect the expression of viral oncogenes and cellular genes involved in proliferation and apoptosis. This model provides a valuable tool to dissect how histone deficiency impacts HPV-16-positive cancer cell biology, including potential effects on DNA replication stress, cell cycle progression, and sensitivity to epigenetic therapeutics.

These H4C1 knockout polyclonal cells are suitable for a wide range of applications in chromatin biology and cancer research. Typical assays include western blotting to confirm loss of H4 protein, RT-qPCR for assessing transcriptional changes, immunofluorescence to visualize chromatin alterations, and flow cytometry for analyzing cell cycle perturbations. Genomic approaches such as RNA-seq and ATAC-seq can reveal transcriptomic and chromatin accessibility changes upon H4C1 disruption, while ChIP-qPCR allows examination of specific histone modifications. Proliferation and apoptosis assays offer functional readouts of oncogenic signaling. Researchers studying HPV-host chromatin interactions, epigenetic dysregulation, or DNA replication stress will find this model instrumental. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)